Dose-Escalation Study to Evaluate the Safety and Tolerability of Intravitreal vMCO-I in Patients With Advanced Retinitis Pigmentosa
Clinical trial NCT04919473 · COMPLETED
Trial details
- NCT number
- NCT04919473
- Sponsor
- Nanoscope Therapeutics Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-23
- Primary completion
- 2020-02-25
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.